Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala
J P
JP
Department of Paediatrics, University of British Columbia, Vancouver, Canada.
Rogers
P C
PC
Chan
K W
KW
Chao
H Y
HY
Rodriguez
W C
WC
D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D002470:Cell Survival / Q000187:drug effects; D003114:Colony-Forming Units Assay; D003676:Deferoxamine; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007501:Iron / Q000378:metabolism; D009447:Neuroblastoma / Q000601:surgery*; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
D007501:Iron; D003676:Deferoxamine